Michael Catelani
Chief Financial Officer, Anixa Biosciences Inc.
Companies
- Anixa Biosciences IncPresident Apr 15, 2022 to now1
- Anixa Biosciences IncChief operating officer Jul 25, 2017 to now2
- Anixa Biosciences IncChief financial officer Nov 9, 2016 to now3
- Anixa Biosciences IncBoard member Sep 20, 2019 to Sep 20, 20194
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Anixa Biosciences Inc ANIX50,000 shares5$133.1K at $2.66Sep 30, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 30, 2026Bought 5,500 shares at $2.84 of Anixa Biosciences Inc5
- Jan 15, 2025Bought 9,289 shares at $2.15 of Anixa Biosciences Inc6
- Jun 7, 2024Bought 6,250 shares at $2.40 of Anixa Biosciences Inc7
- Apr 30, 2024Granted 1,189 shares at $2.52 of Anixa Biosciences Inc8
- Oct 31, 2023Granted 1,117 shares at $2.69 of Anixa Biosciences Inc9
- Jul 20, 2023Bought 5,500 shares at $3.64 of Anixa Biosciences Inc10
- Apr 28, 2023Granted 865 shares at $3.47 of Anixa Biosciences Inc11
- Oct 31, 2022Other 1,069 shares at $2.81 of Anixa Biosciences Inc12
- Apr 29, 2022Other 1,086 shares at $2.76 of Anixa Biosciences Inc13
- Apr 21, 2022Bought 5,500 shares at $2.66 of Anixa Biosciences Inc14
- Apr 20, 2022Bought 2,509 shares at $2.53 of Anixa Biosciences Inc15
- Oct 29, 2021Other 743 shares at $4.04 of Anixa Biosciences Inc16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAnixa Biosciences Inc, President
- 2
- 3
- 4SEC EDGARAnixa Biosciences Inc, Board member
- 5
- 6SEC EDGARForm 4 filed Jan 15, 2025
- 7SEC EDGARForm 4 filed Jun 7, 2024
- 8SEC EDGARForm 4 filed May 2, 2024
- 9SEC EDGARForm 4 filed Nov 2, 2023
- 10SEC EDGARForm 4 filed Jul 21, 2023
- 11SEC EDGARForm 4 filed May 1, 2023
- 12SEC EDGARForm 4 filed Nov 1, 2022
- 13SEC EDGARForm 4 filed May 2, 2022
- 14SEC EDGARForm 4 filed Apr 22, 2022
- 15SEC EDGARForm 4 filed Apr 21, 2022
- 16SEC EDGARForm 4 filed Nov 2, 2021